Optimind Pharma Corp.
OMND
CNSX
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 95.45% | 89.42% | 84.85% | 66.51% | 65.72% |
| Total Depreciation and Amortization | -- | -- | -- | -100.00% | -86.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.86% | -99.87% | -- | -72.10% | -71.75% |
| Change in Net Operating Assets | -62.00% | -153.41% | -98.58% | 371.76% | 228.16% |
| Cash from Operations | 112.30% | -170.45% | 55.39% | 68.77% | 76.84% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 99.69% | 85.39% |
| Cash from Investing | -- | -- | -- | 99.69% | 85.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 83.33% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 1,488.73% | 972.57% | 734.08% | 663.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.85% | 73.99% | 110.60% | 109.24% | 102.57% |